SCHEMBL13680671

SCHEMBL13680671

CC(=O)Cn1cc(-c2cccc(C)n2)cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.44
TGFBR1 P36897 9/20 0.41
CCR1 P32246 1/20 0.41
CCR8 P51685 1/20 0.41
MAPT P10636 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
PKM P14618 1/20 0.40
PIM1 P11309 1/20 0.39
IRAK4 Q9NWZ3 1/20 0.38
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38
TYK2 P29597 1/20 0.38
JAK3 P52333 1/20 0.38
RORC P51449 1/20 0.38
HTT P42858 1/20 0.38
BTK Q06187 1/20 0.37
CCNC P24863 1/20 0.37
FLT3 P36888 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16785592 0.78 TGFBR1 (0.45) CYP2A6TGFBR1CCR1CCR8MAPT
SCHEMBL14819954 0.77 JAK2 (0.44) CYP2A6TGFBR1CCR1CCR8PIM1
SCHEMBL13680646 0.76 EIF2AK2 (0.46)
SCHEMBL27091383 0.75 MAPK1 (0.42) CYP2A6TGFBR1MAPTKDM4EALDH1A1
SCHEMBL20599739 0.75 NAMPT (0.44) CYP2A6TGFBR1CCR1CCR8IRAK4
SCHEMBL29077594 0.74 TGFBR1 (0.39) CYP2A6TGFBR1IRAK4RORCHTT
SCHEMBL27090747 0.73 TGFBR1 (0.44) CYP2A6TGFBR1CCR1CCR8IRAK4
SCHEMBL12269967 0.72 CCR1 (0.52) CYP2A6TGFBR1CCR1CCR8MAPT
SCHEMBL30625193 0.72 CCR1 (0.52) CYP2A6TGFBR1CCR1CCR8MAPT
SCHEMBL3806972 0.72 PDK2 (0.45) MAPTKDM4EALDH1A1LMNAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582658-B2 Bicyclic compound ASAHI KASEI PHARMA CORPORATION (JP) 2009-09-01 US disclosed
US-7582658-B2 Bicyclic compound ASAHI KASEI PHARMA CORPORATION (JP) 2009-09-01 US disclosed